WS #16404

The dominant market narrative has shifted from geopolitical escalation to a sharp reassessment of AI infrastructure economics. The most significant development is the widening of CoreWeave's CDS by 66bp to 1,162bp, coupled with OpenAI cutting its valuation target from $1.4T to $1.25T. This signals a structural repricing of the AI capex boom, directly pressuring high-multiple AI infrastructure plays like CoreWeave ($CRWV) and Meta ($META), while creating a defensive posture for the broader tech sector. This financial tightening counters the previous bullish AI narrative, suggesting that the 'build-out' phase is facing capital constraints. Simultaneously, Brent crude has surged above $117, driven by renewed Middle East tensions and supply risks near the Strait of Hormuz. This oil spike is acting as a drag on global equities, particularly in Europe where the DAX fell 0.86%, and is creating a mixed impact on US indices. While energy names like Exxon ($XOM) and Chevron ($CVX) benefit, the cost-push inflation from oil pressures consumer discretionary and airlines. The combination of rising energy costs and tightening AI financing creates a 'stagflation-lite' environment that is weighing on risk assets. In the equity markets, a notable divergence is emerging. While the broader market is under pressure, specific biotech and energy stories are moving independently. Moderna ($MRNA) plunged 18% on disappointing melanoma vaccine data, erasing $12B in market cap. Conversely, Commonwealth Fusion Systems secured $85M in government funding for fusion semiconductors, highlighting the government's continued support for advanced energy despite private sector caution. The tech sector is also facing headwinds from regulatory scrutiny, with the SEC flagging tokenization as a high-risk area, adding to the defensive tone.